Megestrol for nausea and vomiting from chemotherapy
Treatments studied
Part of Cancer, Digestive system clinical trials.
This study tests a new form of the drug megestrol (a medicine that helps with nausea and vomiting) for people receiving their first chemotherapy. It aims to see if it works better than the standard care to prevent the nausea and vomiting that often happens after chemo.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 or older.
- You must have a confirmed solid tumor (not leukemia or lymphoma).
- You must have never had chemotherapy before, and be about to start a type that often causes nausea and vomiting.
- You must be in good overall condition, able to care for yourself, and expected to live at least 6 more months.
- Your blood counts, liver, and kidney function must be within acceptable ranges.
- You must not have serious heart problems or uncontrolled high blood pressure.
- You must not have an active infection like hepatitis B or C, HIV, or syphilis.
- For women able to have children, a negative pregnancy test is required, and both men and women must use effective birth control during the study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether megestrol acetate (a hormone-like drug) can help prevent nausea and vomiting caused by strong chemotherapy drugs. It is designed for people with lung cancer who are about to start chemotherapy.
This study tests an anti-nausea drug (nano-crystalline megestrol acetate) to see if it helps prevent nausea and vomiting caused by chemotherapy in people with stomach cancer. If you are starting your first chemotherapy, this may help you feel better during treatment.
This trial tests if taking megestrol acetate (a medicine used to stimulate appetite and help gain weight) can reduce weight loss caused by chemotherapy in people with locally advanced colorectal cancer. It may help you maintain strength and energy during treatment.
This trial tests a newer form of megestrol acetate (a medication that can help with appetite and weight) given alongside standard chemotherapy and radiation for locally advanced cervical cancer that cannot be removed by surgery. The study aims to see if this combination is safe and effective.
This study tests a new form of megestrol (a medicine that can boost appetite and energy) for people with advanced stomach or colorectal cancer who also have fatigue and poor appetite. It is given as a first treatment, meaning you haven't had chemotherapy yet for your advanced cancer.
This study tests a new form of megestrol, a medicine that helps stimulate appetite and promote weight gain, in people with advanced non-small cell lung cancer who are starting their first chemotherapy and are at risk of malnutrition. The goal is to see if it improves nutrition and overall well-being during treatment.
Hear when a new Malignant Solid Tumors trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.